Cannabis-based products either come from the cannabis plant (marijuana) or they can be synthetic. Synthetic products are human-made chemicals that have the same chemical structures as CBD and THC. All cannabis-based medicines currently available are derived from the cannabis plant and are not synthetic.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Cannabis-based Medicines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Market Segment by Product Application
Oral Solution
Tablets
Patches
Others
Finally, the report provides detailed profile and data information analysis of leading company.
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Cannabis-based Medicines consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Cannabis-based Medicines market by identifying its various subsegments.
3.Focuses on the key global Cannabis-based Medicines manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cannabis-based Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cannabis-based Medicines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Cannabis-based Medicines Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Cannabis-based Medicines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Cannabis-based Medicines Segment by Type
2.1.1 CBD (Cannabidiol) Based
2.1.2 THC (Tetrahydrocannabinol) Based
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Oral Solution
2.2.2 Tablets
2.2.3 Patches
2.2.4 Others
2.3 Global Cannabis-based Medicines Market Comparison by Regions (2017-2027)
2.3.1 Global Cannabis-based Medicines Market Size (2017-2027)
2.3.2 North America Cannabis-based Medicines Status and Prospect (2017-2027)
2.3.3 Europe Cannabis-based Medicines Status and Prospect (2017-2027)
2.3.4 China Cannabis-based Medicines Status and Prospect (2017-2027)
2.3.5 Japan Cannabis-based Medicines Status and Prospect (2017-2027)
2.3.6 Southeast Asia Cannabis-based Medicines Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Cannabis-based Medicines Industry Impact
2.5.1 Cannabis-based Medicines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Cannabis-based Medicines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Cannabis-based Medicines Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Cannabis-based Medicines Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Cannabis-based Medicines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Cannabis-based Medicines Manufacturer Market Share
3.5 Top 10 Cannabis-based Medicines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Cannabis-based Medicines Market
3.7 Key Manufacturers Cannabis-based Medicines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Cannabis-based Medicines Industry Key Manufacturers
4.1 GW Pharmaceuticals plc
4.1.1 Compan Detail
4.1.2 GW Pharmaceuticals plc Cannabis-based Medicines Product Introduction, Application and Specification
4.1.3 GW Pharmaceuticals plc 132 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GW Pharmaceuticals plc News
4.2 INSYS Therapeutics
4.2.1 Compan Detail
4.2.2 INSYS Therapeutics Cannabis-based Medicines Product Introduction, Application and Specification
4.2.3 INSYS Therapeutics Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GW Pharmaceuticals plc News
4.3 Aequus Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Aequus Pharmaceuticals Cannabis-based Medicines Product Introduction, Application and Specification
4.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Aequus Pharmaceuticals News
4.4 Axim Biotechnologies
4.4.1 Compan Detail
4.4.2 Axim Biotechnologies Cannabis-based Medicines Product Introduction, Application and Specification
4.4.3 Axim Biotechnologies Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Axim Biotechnologies News
4.5 Revive Therapeutics
4.5.1 Compan Detail
4.5.2 Axim Biotechnologies Cannabis-based Medicines Product Introduction, Application and Specification
4.5.3 Revive Therapeutics Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Revive Therapeutics News
4.6 MGC Pharmaceuticals
4.6.1 Compan Detail
4.6.2 MGC Pharmaceuticals Cannabis-based Medicines Product Introduction, Application and Specification
4.6.3 MGC Pharmaceuticals Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 MGC Pharmaceuticals News
4.7 ECHO Pharmaceuticals
4.7.1 Compan Detail
4.7.2 ECHO Pharmaceuticals Cannabis-based Medicines Product Introduction, Application and Specification
4.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Cannabis-based Medicines Market Segment by Big Type
5.1 Global Cannabis-based Medicines Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Cannabis-based Medicines Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Cannabis-based Medicines Revenue and Market Share by Big Type (2017-2022)
5.2 CBD (Cannabidiol) Based Sales Growth Rate and Price
5.2.1 Global CBD (Cannabidiol) Based Sales Growth Rate (2017-2022)
5.2.2 Global CBD (Cannabidiol) Based Price (2017-2022)
5.3 THC (Tetrahydrocannabinol) Based Sales Growth Rate and Price
5.3.1 Global THC (Tetrahydrocannabinol) Based Sales Growth Rate (2017-2022)
5.3.2 Global THC (Tetrahydrocannabinol) Based Price (2017-2022)
5.4 Others Sales Growth Rate and Price
5.4.1 Global Others Sales Growth Rate (2017-2022)
5.4.2 Global Others Price (2017-2022)
6 Global Cannabis-based Medicines Market Segment by Big Application
6.1 Global Cannabis-based Medicines Sales Market Share by Big Application (2017-2022)
6.2 Oral Solution Sales Growth Rate (2017-2022)
6.3 Tablets Sales Growth Rate (2017-2022)
6.4 Patches Sales Growth Rate (2017-2022)
6.5 Others Sales Growth Rate (2017-2022)
7 Global Cannabis-based Medicines Forecast
7.1 Global Cannabis-based Medicines Revenue, Sales and Growth Rate (2022-2027)
7.2 Cannabis-based Medicines Market Forecast by Regions (2022-2027)
7.2.1 North America Cannabis-based Medicines Market Forecast (2022-2027)
7.2.2 Europe Cannabis-based Medicines Market Forecast (2022-2027)
7.2.3 China Cannabis-based Medicines Market Forecast (2022-2027)
7.2.4 Japan Cannabis-based Medicines Market Forecast (2022-2027)
7.2.5 Southeast Asia Cannabis-based Medicines Market Forecast (2022-2027)
7.2.6 Other Regions Cannabis-based Medicines Market Forecast (2022-2027)
7.3 Cannabis-based Medicines Market Forecast by Type (2022-2027)
7.3.1 Global Cannabis-based Medicines Sales Forecast by Type (2022-2027)
7.3.2 Global Cannabis-based Medicines Market Share Forecast by Type (2022-2027)
7.4 Cannabis-based Medicines Market Forecast by Application (2022-2027)
7.4.1 Global Cannabis-based Medicines Sales Forecast by Application (2022-2027)
7.4.2 Global Cannabis-based Medicines Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Cannabis-based Medicines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Cannabis-based Medicines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Cannabis-based Medicines
Figure Market Concentration Ratio and Market Maturity Analysis of Cannabis-based Medicines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Cannabis-based Medicines Market Size by Big Type
Figure Global Market Share of Cannabis-based Medicines by Big Type in 2021
Figure CBD (Cannabidiol) Based Picture (2017-2022)
Figure THC (Tetrahydrocannabinol) Based Picture (2017-2022)
Global Cannabis-based Medicines Market Size by Big Application
Table Global Cannabis-based Medicines Market Size by Application
Figure Global Cannabis-based Medicines Market Share by Big Application in 2021
Figure Oral Solution Picture
Figure Tablets Picture
Figure Patches Picture
Figure Others Picture
Table Global Cannabis-based Medicines Comparison by Regions (M USD) (2017-2027)
Figure Global Cannabis-based Medicines Market Size (Million US$) (2017-2027)
Figure North America Cannabis-based Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Cannabis-based Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure China Cannabis-based Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Cannabis-based Medicines Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Cannabis-based Medicines Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Cannabis-based Medicines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Cannabis-based Medicines Sales by Manufacturer (2017-2022)
Figure Global Cannabis-based Medicines Sales Market Share by Manufacturer in 2021
Table Global Cannabis-based Medicines Revenue by Manufacturer (2017-2022)
Figure Global Cannabis-based Medicines Revenue Market Share by Manufacturer in 2021
Table Global Cannabis-based Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Cannabis-based Medicines Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Cannabis-based Medicines Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Cannabis-based Medicines Market
Table Key Manufacturers Cannabis-based Medicines Product Type
Table Mergers & Acquisitions Planning
Table GW Pharmaceuticals plc Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of GW Pharmaceuticals plc
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table INSYS Therapeutics Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of INSYS Therapeutics
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table INSYS Therapeutics Recent Development
Table Aequus Pharmaceuticals Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of Aequus Pharmaceuticals
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aequus Pharmaceuticals Main Business
Table Aequus Pharmaceuticals Recent Development
Table Axim Biotechnologies Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of Axim Biotechnologies
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Axim Biotechnologies Main Business
Table Axim Biotechnologies Recent Development
Table Axim Biotechnologies Main Business
Table Axim Biotechnologies Recent Development
Table Revive Therapeutics Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of Revive Therapeutics
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Revive Therapeutics Main Business
Table Revive Therapeutics Recent Development
Table MGC Pharmaceuticals Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of MGC Pharmaceuticals
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MGC Pharmaceuticals Main Business
Table MGC Pharmaceuticals Recent Development
Table ECHO Pharmaceuticals Company Profile
Table Cannabis-based Medicines Product Introduction, Application and Specification of ECHO Pharmaceuticals
Table Cannabis-based Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ECHO Pharmaceuticals Main Business
Table ECHO Pharmaceuticals Recent Development
Figure Global Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure Global Cannabis-based Medicines Revenue and Growth Rate (2017-2022)
Table Global Cannabis-based Medicines Sales by Regions (2017-2022)
Figure Global Cannabis-based Medicines Sales Market Share by Regions in 2021
Table Global Cannabis-based Medicines Revenue by Regions (2017-2022)
Figure Global Cannabis-based Medicines Revenue Market Share by Regions in 2021
Figure North America Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure Europe Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure China Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure Japan Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure Southeast Asia Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Figure Other Regions Cannabis-based Medicines Sales and Growth Rate (2017-2022)
Table Global Cannabis-based Medicines Sales by Big Type (2017-2022)
Table Global Cannabis-based Medicines Sales Market Share by Big Type (2017-2022)
Figure Global Cannabis-based Medicines Sales Market Share by Big Type in 2019
Table Global Cannabis-based Medicines Revenue by Big Type (2017-2022)
Table Global Cannabis-based Medicines Revenue Market Share by Big Type (2017-2022)
Table Global Cannabis-based Medicines Revenue Market Share by Big Type in 2019
Figure Global CBD (Cannabidiol) Based Sales Growth Rate (2017-2022)
Figure Global CBD (Cannabidiol) Based Price (2017-2022)
Figure Global THC (Tetrahydrocannabinol) Based Sales Growth Rate (2017-2022)
Figure Global THC (Tetrahydrocannabinol) Based Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Cannabis-based Medicines Sales by Big Application (2017-2022)
Table Global Cannabis-based Medicines Sales Market Share by Big Application (2017-2022)
Figure Global Cannabis-based Medicines Sales Market Share by Big Application in 2019
Figure Global Oral Solution Sales Growth Rate (2017-2022)
Figure Global Tablets Sales Growth Rate (2017-2022)
Figure Global Patches Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Cannabis-based Medicines Sales and Growth Rate (2022-2027)
Figure Global Cannabis-based Medicines Revenue and Growth Rate (2022-2027)
Table Global Cannabis-based Medicines Sales Forecast by Regions (2022-2027)
Table Global Cannabis-based Medicines Market Share Forecast by Regions (2022-2027)
Figure North America Sales Cannabis-based Medicines Market Forecast (2022-2027)
Figure Europe Sales Cannabis-based Medicines Market Forecast (2022-2027)
Figure China Sales Cannabis-based Medicines Market Forecast (2022-2027)
Figure Japan Sales Cannabis-based Medicines Market Forecast (2022-2027)
Figure Southeast Asia Sales Cannabis-based Medicines Market Forecast (2022-2027)
Figure Other Regions Sales Cannabis-based Medicines Market Forecast (2022-2027)
Table Global Cannabis-based Medicines Sales Forecast by Type (2022-2027)
Table Global Cannabis-based Medicines Market Share Forecast by Type (2022-2027)
Table Global Cannabis-based Medicines Sales Forecast by Application (2022-2027)
Table Global Cannabis-based Medicines Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cannabis-based Medicines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Cannabis-based Medicines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Cannabis-based Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Cannabis-based Medicines Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Cannabis-based Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Cannabis-based Medicines Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Cannabis-based Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Cannabis-based Medicines Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Cannabis-based Medicines Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)